9. Are There Plans for Further Studies?
If more clinical studies are done, they may be listed on public websites, such as
those below. Search for study medicine name denosumab (XGEVA®) on the
websites below.
10. Where Can I Find More Information About This Study?
To find out more about this study, check these websites:
 www.clinicaltrials.gov. Use the study identifier NCT01345019
 www.clinicaltrialsregister.eu. Use the study identifier 2010-020454-34
 Raje N, Terpos E, Willenbacher W, et al. Denosumab versus zoledronic acid
in bone disease treatment of newly diagnosed multiple myeloma: an
international, double-blind, double-dummy, randomised, controlled, phase 3
study. Lancet Oncol. 2018;19(3):370-381. doi: 10.1016/S1470-
2045(18)30072-X.
If you participated in the study and have questions about the study results, the doctor
or staff at your study site may be able to answer them.
12